SCHEMBL16971695

SCHEMBL16971695

Oc1ccnc(-c2cc(Cl)ccc2-n2cc(C(F)(F)F)nn2)n1

nearest known ligand 0.39

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ F11 P03951 19/20 0.39
▸ KLKB1 P03952 17/20 0.39
▸ CYP3A4 P08684 4/20 0.38
▸ F2 P00734 1/20 0.36
▸ F10 P00742 1/20 0.36
▸ CYP1A1 P04798 1/20 0.36
▸ PRSS1 P07477 1/20 0.36
▸ PRSS2 P07478 1/20 0.36
▸ CYP2C8 P10632 1/20 0.36
▸ CYP2D6 P10635 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ PRSS3 P35030 1/20 0.36
▸ NOTUM Q6P988 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29589409 0.85 NOTUM (0.39) F11KLKB1CYP3A4NOTUM
SCHEMBL28360881 0.85 NOTUM (0.39) F11KLKB1CYP3A4NOTUM
SCHEMBL30622131 0.79 NOTUM (0.36) F11NOTUM
SCHEMBL16971418 0.79 F11 (0.40) F11KLKB1CYP3A4F2F10
SCHEMBL30995054 0.78 F11 (0.44) F11KLKB1CYP3A4F2F10
SCHEMBL29227918 0.78 F11 (0.44) F11KLKB1CYP3A4F2F10
SCHEMBL30271787 0.76 F11 (0.43) F11KLKB1F2NOTUM
SCHEMBL29227919 0.76 F11 (0.44) F11KLKB1CYP3A4F2F10
SCHEMBL31252199 0.76 F11 (0.42) F11KLKB1CYP3A4F2F10
SCHEMBL20336037 0.75 F11 (0.42) F11KLKB1CYP3A4F2F10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114957255-A Pyrimidinones as factor XIA inhibitors 百时美施贵宝公司 2022-08-30 — — CN disclosed
CN-110734435-B Pyrimidinones as factor XIA inhibitors 百时美施贵宝公司 2022-06-07 — — CN disclosed
CN-110734435-A Pyrimidinones as factor XIA inhibitors 百时美施贵宝公司 2020-01-31 — — CN disclosed
EP-3099687-A1 MACROCYCLES WITH HETROCYCLIC P2' GROUPS AS FACTOR XIA INHIBITORS Bristol-Myers Squibb Company (US) 2016-12-07 — — EP disclosed
WO-2015116886-A1 MACROCYCLES WITH HETROCYCLIC P2' GROUPS AS FACTOR XIA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2015-08-06 — — WO disclosed
Send feedback